OVID
Ovid TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
OVID vs peer average
71/100
OVID vs. peer average (B vs. C)
Grade spread
B 2 · C 3 · D 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
PRTA is the first available peer comparator.
Clinical-stage neurology biotech with event-driven valuation; useful as a loose comp for how pipeline timing and readout quality can drive sentiment in CNS names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OVID
Ovid Therapeutics
PRTA
Prothena
Grade
B
C
Momentum
93
16
Value
41
41
Sentiment
50
89
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs PRTA
OVID / PRTA
Grade Position
Above peers
OVID vs. peer average (B vs. C)
71/100
Momentum
93
OVIDValue
41
OVIDSentiment
50
PRTARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OVID
PRTA is the first peer returned for this comparison set.

